Medicare Enrolled
Dr. Daniel Spitz, M.D.
Medical Oncology · West Palm Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Spitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Spitz? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Spitz
Dr. Daniel Spitz is a medical oncology in West Palm Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Spitz performed 166,965 Medicare services across 4,042 unique beneficiaries.
Between the years covered by Open Payments, Dr. Spitz received a total of $24,691 from 103 pharmaceutical and/or device companies across 1450 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Spitz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 16% volume in FL$ $24,691 industry payments
Medicare Practice Summary
Medicare Utilization ↗166,965
Medicare services
Top 16% in FL for medical oncology
4,042
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,348 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 39,270 | $0 | $4 |
| Iron sucrose injection (Venofer) | 27,700 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 27,000 | $43 | $137 |
| Filgrastim injection (Zarxio) for white blood cells | 25,920 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 9,221 | $6 | $23 |
| Contrast dye for imaging (iodine-based) | 7,075 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 6,540 | $19 | $51 |
| Immune globulin infusion (Gammagard) | 6,324 | $36 | $108 |
| Anti-nausea injection (aprepitant) | 4,290 | $1 | $5 |
| Blood draw (venipuncture) | 2,553 | $8 | $9 |
| Complete blood count (CBC) with differential | 2,553 | $8 | $29 |
| Office visit, established patient (30-39 min) | 1,438 | $97 | $339 |
| Dexamethasone injection (steroid) | 1,072 | $0 | $3 |
| Drug injection, under skin or into muscle | 909 | $11 | $69 |
| Office visit, established patient (20-29 min) | 680 | $71 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 664 | $0 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 420 | $1 | $28 |
| Administration of chemotherapy into vein, 1 hour or less | 366 | $102 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 349 | $50 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 312 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 255 | $16 | $56 |
| Injection of additional new drug or substance into vein | 247 | $12 | $61 |
| Injection, carboplatin, 50 mg | 216 | $2 | $41 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 160 | $134 | $562 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 141 | $22 | $84 |
| Injection, diphenhydramine hcl, up to 50 mg | 126 | $1 | $3 |
| New patient office visit (45-59 min) | 106 | $127 | $453 |
| Hospital follow-up visit, moderate complexity | 101 | $63 | $197 |
| Administration of chemotherapy into vein, each additional hour | 87 | $23 | $79 |
| Infusion into a vein for hydration, each additional hour | 85 | $10 | $42 |
| Administration of additional new drug or substance into vein, 1 hour or less | 81 | $52 | $178 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 77 | $1,157 | $3,706 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 74 | $401 | $680 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 72 | $24 | $89 |
| CT scan of abdomen and pelvis with contrast | 70 | $179 | $550 |
| Ct scan of chest with contrast | 60 | $53 | $344 |
| Automated urinalysis | 51 | $2 | $8 |
| Infusion, normal saline solution , 1000 cc | 45 | $2 | $7 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 44 | $17 | $59 |
| Infusion into a vein for hydration, 31-60 minutes | 43 | $25 | $156 |
| Injection of drug or substance into vein | 35 | $26 | $156 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 33 | $1 | $7 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 31 | $3 | $11 |
| Red blood count automated, with additional calculations | 30 | $5 | $20 |
| New patient office visit (30-44 min) | 14 | $76 | $298 |
| Office visit, established patient, complex (40-54 min) | 13 | $140 | $474 |
| Echocardiogram, transthoracic | 12 | $103 | $430 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
27.9% high complexity
67.4% medium
4.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,691
Total received (2018-2024)
Avg $3,527/year across 7 years
Top 21% in FL for medical oncology
103
Companies
1,450
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,295 (94.3%)
Other
Charitable contributions, space rental, and other categories
$819 (3.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$577 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,921
2023$4,506
2022$3,556
2021$2,138
2020$1,974
2019$2,849
2018$3,749
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$2,784
Novartis Pharmaceuticals Corporation
$1,704
PFIZER INC.
$1,401
AstraZeneca Pharmaceuticals LP
$1,305
Celgene Corporation
$1,150
Incyte Corporation
$1,020
E.R. Squibb & Sons, L.L.C.
$895
Genentech USA, Inc.
$821
Lilly USA, LLC
$789
Seagen Inc.
$744
GlaxoSmithKline, LLC.
$632
Amgen Inc.
$585
Eisai Inc.
$499
GENZYME CORPORATION
$476
Merck Sharp & Dohme LLC
$472
Merck Sharp & Dohme Corporation
$423
Takeda Pharmaceuticals U.S.A., Inc.
$382
Ipsen Biopharmaceuticals, Inc
$377
Daiichi Sankyo Inc.
$370
NOVARTIS PHARMACEUTICALS CORPORATION
$308
NanoString Technologies, Inc.
$306
SOBI, INC
$300
Astellas Pharma US Inc
$297
Bayer HealthCare Pharmaceuticals Inc.
$266
EISAI INC.
$262
Pharmacyclics LLC, An AbbVie Company
$258
JAZZ PHARMACEUTICALS INC.
$254
Seattle Genetics, Inc.
$242
Alexion Pharmaceuticals, Inc.
$232
Boehringer Ingelheim Pharmaceuticals, Inc.
$228
Foundation Medicine, Inc.
$218
ABBVIE INC.
$208
Regeneron Healthcare Solutions, Inc.
$204
BeiGene USA, Inc.
$199
Blueprint Medicines Corporation
$173
Rigel Pharmaceuticals, Inc.
$173
Kite Pharma, Inc.
$150
Adaptive Biotechnologies Corporation
$147
Clovis Oncology, Inc.
$144
Bayer Healthcare Pharmaceuticals Inc.
$123
Agios Pharmaceuticals, Inc.
$120
Aurobindo Pharma USA, Inc.
$118
EMD Serono, Inc.
$108
ADC Therapeutics America, Inc.
$105
Menarini Silicon Biosystems, Inc.
$98
ARRAY BIOPHARMA INC
$96
TerSera Therapeutics LLC
$92
Dova Pharmaceuticals
$92
Pharmacosmos Therapeutics Inc.
$91
Tempus AI, Inc
$91
AbbVie, Inc.
$89
Karyopharm Therapeutics Inc.
$88
Puma Biotechnology, Inc.
$88
Gilead Sciences, Inc.
$79
Heron Therapeutics, Inc.
$76
Kyowa Kirin, Inc.
$73
Janssen Pharmaceuticals, Inc
$72
Napo Pharmaceuticals Inc
$71
Pharmacyclics LLC, an AbbVie Company
$70
Lexicon Pharmaceuticals, Inc.
$70
Sirtex Medical Inc
$64
Exelixis Inc.
$63
Shire North American Group Inc
$61
AbbVie Inc.
$58
Octapharma USA, Inc.
$56
RECORDATI_RARE_DISEASES_INC.
$50
Dendreon Pharmaceuticals LLC
$50
MEDIVATION FIELD SOLUTIONS LLC
$46
PharmaEssentia USA Corporation
$45
Emmaus Medical, Inc.
$43
Advanced Accelerator Applications
$42
Otsuka America Pharmaceutical, Inc.
$42
TESARO, Inc.
$40
Alnylam Pharmaceuticals Inc.
$39
G1 Therapeutics, Inc.
$39
Sobi, Inc
$38
Spectrum Pharmaceuticals Inc.
$38
MorphoSys, US Inc.
$38
Cumberland Pharmaceuticals, Inc.
$35
Medtronic, Inc.
$32
Myriad Genetic Laboratories, Inc.
$31
Secura Bio, Inc.
$30
Aveo Pharmaceuticals, Inc.
$27
PUMA BIOTECHNOLOGY, INC.
$26
Genmab U.S., Inc.
$26
Janssen Scientific Affairs, LLC
$25
Deciphera Pharmaceuticals Inc.
$24
Taiho Oncology, Inc.
$22
SERVIER PHARMACEUTICALS LLC
$22
Shield Therapeutics Inc
$22
Amneal Pharmaceuticals LLC
$21
Partner Therapeutics, Inc.
$20
TAIHO ONCOLOGY, INC.
$19
Sun Pharmaceutical Industries Inc.
$19
Jazz Pharmaceuticals Inc.
$19
Verastem, Inc.
$19
AVEO Pharmaceuticals, Inc.
$18
TG THERAPEUTICS, INC.
$17
Legend Biotech USA Inc.
$15
SHIELD THERAPEUTICS INC
$15
Global Blood Therapeutics, Inc.
$14
Innate Pharma, Inc
$14
Veracyte, Inc.
$2
Top 3 companies account for 23.8% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cellsearch · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Endari · Enhertu · Epkinly · FARYDAK · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · Folotyn · GAZYVA · GELCLAIR CONCENTRATED ORAL GEL · GILOTRIF · HEMLIBRA · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LEUKINE · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONIVYDE · ONPATTRO · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYLVANT · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOTRIENT · VPRIV · VYXEOS · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · Zoladex · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $15 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
21
Per 100K population
1.4
County median income
$81,115
Nearest hospital
GOOD SAMARITAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Spitz is a mixed practice specialist, with above-average Medicare volume (top 16% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Spitz experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Spitz performed 39,270 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Spitz receive payments from pharmaceutical companies?
Yes. Dr. Spitz received a total of $24,691 from 103 companies across 1,450 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Spitz's costs compare to other medical oncologys in West Palm Beach?
Dr. Spitz's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Spitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in West Palm Beach
Browse medical oncologys in West Palm Beach ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology